96
Participants
Start Date
December 31, 2008
Primary Completion Date
May 31, 2009
Vildagliptin
Mild, moderate and severe renal impaired patients receiving 25 mg vildagliptin once daily
Vildagliptin
Mild, moderate and severe renal impaired patients receiving 50 mg vildagliptin once daily
Vildagliptin
Matching healthy volunteers receiving 25 mg vildagliptin once daily.
Vildagliptin
Matching healthy volunteers receiving 50 mg vildagliptin once daily
Novartis Investigator Site, Moscow
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY